Microparticle-based platform for point-of-care immunoassays

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Nanotechnology

Background:

• Point-of-care (POC) immunoassays require high sensitivity, quantitative results, and simplicity.
• Existing POC assays often compromise performance for usability or vice versa.
• A need exists for integrated platforms overcoming these limitations.

Purpose of the Study:

• To develop a novel microparticle-based immunoassay platform for POC applications.
• To combine the analytical performance of microtiter well assays with the convenience of rapid tests.
• To demonstrate the platform's feasibility using a cardiac troponin I assay.

Main Methods:

• Developed a POC microparticle-based immunoassay platform with separate reaction and detection chambers.
• Utilized microparticles as the solid-phase support.
• Employed photoluminescent up-converting nanoparticles (UCNPs) as labels for detection.

Main Results:

• Achieved a limit of detection of 19.7 ng/L for cardiac troponin I.
• Demonstrated the platform's ability to integrate high performance with POC usability.
• Validated the platform's feasibility for detecting various target analytes.

Conclusions:

• The developed microparticle-based immunoassay platform is a viable solution for sensitive and simple POC diagnostics.
• UCNP labeling offers a sensitive detection mechanism for this platform.
• The platform shows potential for broad application in POC testing across different analytes.